An overview of the vaccine adverse event reporting system (VAERS) as a surveillance system

被引：135
|
作者：
Singleton, JA
Lloyd, JC
Mootrey, GT
Salive, ME
Chen, RT
机构：
[1] Ctr Dis Control & Prevent, Natl Immunizat Program, Vaccine Safety & Dev Author, Atlanta, GA 30333 USA
[2] US FDA, Div Biostat & Epidemiol, Rockville, MD 20857 USA
来源：
VACCINE | 1999年 / 17卷 / 22期
关键词：
vaccines; postmarketing surveillance; adverse effects;
D O I：
10.1016/S0264-410X(99)00132-2
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
We evaluated the Vaccine Adverse Event Reporting System (VAERS), the spontaneous reporting system for vaccine-associated adverse events in the United Slates, as a public health surveillance system, using evaluation guidelines from the Centers for Disease Control and Prevention. We found that VAERS is simple for reporters to use, flexible by design and its data are available in a timely fashion. The predictive value positive for one severe event is known to be high, but for most events is unknown. The acceptability, sensitivity and representativeness of VAERS are unknown, The study of vaccine safety is complicated by underreporting, erroneous reporting, frequent multiple exposures and multiple outcomes. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码：2908 / 2917
页数：10
相关论文
共 50 条
  • [21] Vaccine adverse event reporting system (VAERS): Evaluation of 31 years of reports and pandemics' impact
    Almadani, Ohoud A.
    Alshammari, Thamir M.
    [J]. SAUDI PHARMACEUTICAL JOURNAL, 2022, 30 (12) : 1725 - 1735
  • [22] The Vaccine Adverse Event Reporting System
    Varricchio, F
    [J]. JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY, 1998, 36 (07): : 765 - 768
  • [23] The temporal relationship between RotaTeq immunization and intussusception adverse events in the Vaccine Adverse Event Reporting System (VAERS)
    Geier, David A.
    King, Paul G.
    Sykes, Lisa K.
    Geier, Mark R.
    [J]. MEDICAL SCIENCE MONITOR, 2012, 18 (02): : PH12 - PH17
  • [24] Adverse events after Fluzone® Intradermal vaccine reported to the Vaccine Adverse Event Reporting System (VAERS), 2011-2013
    Moro, Pedro L.
    Harrington, Theresa
    Shimabukuro, Tom
    Cano, Maria
    Museru, Oidda I.
    Menschik, David
    Broder, Karen
    [J]. VACCINE, 2013, 31 (43) : 4984 - 4987
  • [25] Otorhinolaryngologic complications after COVID-19 vaccination, vaccine adverse event reporting system (VAERS)
    Shin, Jieun
    Shim, Sung Ryul
    Lee, Jaekwang
    Ryu, Hyon Shik
    Kim, Jong-Yeup
    [J]. FRONTIERS IN PUBLIC HEALTH, 2024, 11
  • [26] Vaccination of persons allergic to latex: a review of safety data in the Vaccine Adverse Event Reporting System (VAERS)
    Russell, M
    Pool, V
    Kelso, JA
    Tomazic-Jezic, VJ
    [J]. VACCINE, 2004, 23 (05) : 664 - 667
  • [27] Two-year review of hepatitis A vaccine safety: Data from the Vaccine Adverse Event Reporting System (VAERS)
    Niu, MT
    Salive, M
    Krueger, C
    Ellenberg, SS
    [J]. CLINICAL INFECTIOUS DISEASES, 1998, 26 (06) : 1475 - 1476
  • [28] Safety of anthrax vaccine: a review by the Anthrax Vaccine Expert Committee (AVEC) of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS)
    Sever, JL
    Brenner, AI
    Gale, AD
    Lyle, JM
    Moulton, LH
    West, DJ
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2002, 11 (03) : 189 - 202
  • [29] Follow-up study of medication errors reported to the vaccine adverse event reporting system (VAERS)
    Varricchio, Frederick
    Reed, John
    [J]. SOUTHERN MEDICAL JOURNAL, 2006, 99 (05) : 486 - 489
  • [30] Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990-2007
    Niu, Manette T.
    Ball, Robert
    Woo, Emily Jane
    Burwen, Dale R.
    Knippen, Maureen
    Braun, M. Miles
    [J]. VACCINE, 2009, 27 (02) : 290 - 297
12345